Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M205Revenue $M98.0Net Margin (%)6.0Altman Z-Score1.6
Enterprise Value $M178EPS $0.1Operating Margin %6.7Piotroski F-Score6
P/E(ttm)33.5Beneish M-Score-2.8Pre-tax Margin (%)6.0Higher ROA y-yY
Price/Book4.410-y EBITDA Growth Rate %--Quick Ratio1.8Cash flow > EarningsY
Price/Sales2.15-y EBITDA Growth Rate %--Current Ratio2.1Lower Leverage y-yN
Price/Free Cash Flow21.2y-y EBITDA Growth Rate %--ROA % (ttm)9.1Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)15.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M46.1ROIC % (ttm)27.7Gross Margin Increase y-yY

Gurus Latest Trades with ENZ

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ENZDodge & Cox 2014-12-31 Sold Out $4.1 - $5.27
($4.76)
$ 4.45-7%Sold Out0
ENZDodge & Cox 2014-09-30 Buy $4.55 - $6.08
($5.34)
$ 4.45-17%New holding15,570
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ENZ is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ENZ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KASTEN BERNARD LDirector 2014-10-24Sell15,900$4.93-9.74view
RABBANI ELAZARCEO and Secretary 2011-11-16Buy20,000$2.2994.32view
WEINER BARRY WPres, CFO, Princ AO and Treasr 2011-11-16Buy20,000$2.2994.32view
BALEZENTIS CARL WPres., Enzo Life Sciences 2010-12-15Sell12,724$5.12-13.09view
Kent Stephen B HDirector 2010-10-22Sell8,000$4.33.49view
Kent Stephen B HDirector 2010-08-05Sell2,500$4.47-0.45view
Kent Stephen B HDirector 2010-06-11Sell5,000$4.293.73view
Kent Stephen B HDirector 2010-03-15Sell5,000$6.15-27.64view
KRENITSKY KEVINPresident, Enzo Clinical Labs 2009-10-15Buy6,600$7.7-42.21view
BALEZENTIS CARL WPresident, Enzo Life Sciences 2008-10-30Sell580$5.35-16.82view

Quarterly/Annual Reports about ENZ:

News about ENZ:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: BWEN, DDMG, ZHNE, ENZ, SIRO Nov 28 2011 
Weekly CFO Buys Highlight: BWEN, ENZ, PIP, HAFC, AACC Nov 21 2011 
Enzo Biochem Inc. Reports Operating Results (10-Q) Mar 14 2011 
Enzo Biochem Inc. Reports Operating Results (10-Q) Dec 10 2010 
Enzo Biochem Inc. Reports Operating Results (10-Q) Jun 09 2010 
Enzo Biochem Inc. Reports Operating Results (10-Q) Dec 10 2009 
Weekly Top Insider Buys: Bank of America Corp., Safeway Inc., Umpqua Holdings Corp., National Penn B Oct 24 2009 
Weekly Top Insider Buys: KB Home, National Penn Bancshares Inc., Moduslink Global Solutions Inc., En Oct 20 2009 
Enzo Biochem Inc. Reports Operating Results (10-Q) Sep 04 2009 
Enzo Biochem Inc. (ENZ) Files Quarterly Report for the Period Ended on 2008-10-31 Dec 15 2008 

More From Other Websites
ENZO Biochem Collects $7 Million From Court Approved Escrow Fund Closings Jan 26 2016
ENZO BIOCHEM INC Files SEC form 8-K, Other Events Jan 26 2016
Enzo Biochem Collects $7 Million from Court Approved Escrow Fund Closings Jan 26 2016
ENZO BIOCHEM INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jan 08 2016
ENZO Biochem Announces Patent Infringement Settlement with Agilent Technologies Jan 07 2016
ENZO BIOCHEM INC Files SEC form 8-K, Other Events Jan 06 2016
ENZO Biochem Updates Corporate Developments at Annual Shareholders Meeting Jan 06 2016
Enzo Biochem Updates Corporate Developments at Annual Shareholders Meeting Jan 06 2016
ENZO Biochem Reaches $9 Million Patent Infringement Settlement with Agilent Technologies, Inc.... Jan 06 2016
Enzo Biochem Reaches $9 Million Patent Infringement Settlement with Agilent Technologies, Inc. Jan 06 2016
ENZO BIOCHEM INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Dec 30 2015
Enzo Comments on Lone Star’s Decision to Withdraw Its Proxy Contest Dec 30 2015
Lone Star Value Issues Statement To Fellow Enzo Shareholders Dec 29 2015
ENZO BIOCHEM INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Dec 28 2015
ISS Endorses Enzo’s Nominees for Company’s Board of Directors Dec 28 2015
ENZO BIOCHEM INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Dec 23 2015
Glass Lewis Supports Enzo Nominees for Company’s Board of Directors Dec 23 2015
Enzo Biochem Issues Open Letter to Shareholders Dec 22 2015
Lone Star Value Issues Open Letter to Shareholders of Enzo Biochem, Inc. Dec 22 2015
ENZO BIOCHEM INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Dec 21 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK